CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to MRK

Pembrolizumab (MK-3475)

Phase 3
MERCK (MRK)

Phase 3

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Apr '27
MRKPhase 2

Pembrolizumab (MK-3475) Phase 2 Est. Readout

Pembrolizumab (MK-3475)
Apr 2027~
CT.gov
00%
Competitive Landscape

0 competitors in Merkel Cell Carcinoma

View Full Landscape
Drug Information

Target Indication

Merkel Cell Carcinoma

Clinical Trial

NCT03783078

Last updated: 1/8/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.